Exploring the role of Teneurin-4 in solid tumours: current evidence and potential therapeutic implications

Davide Loggia1, Giulia Peppino1, Chiara Vit1

  • 1Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, 10126, Italy.

Cancer Letters
|June 20, 2026
PubMed

Insights

Teneurin-4 (TENM4) is linked to cancer progression and cell plasticity. Further research is needed to validate its role in tumour biology and potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Teneurin-4 (TENM4) expression is deregulated across various cancer types, but its functional role in tumor biology is not fully understood.
  • Existing evidence, primarily correlative and in silico, suggests TENM4 upregulation in breast, lung, colon, gastric, pancreatic cancers, and brain tumors.

Purpose of the Study:

  • To review current knowledge on TENM4 expression, structure, and molecular interactions in physiological and pathological settings.
  • To discuss TENM4's potential role in tumor cell plasticity, migration, and stem-like properties, particularly in triple-negative breast cancer (TNBC).
  • To identify knowledge gaps and the need for further validation of TENM4's function in cancer.

Main Methods:

  • Literature review of existing studies on TENM4 expression patterns.
  • Analysis of available interactome data and proposed TENM4-associated signaling networks.
  • Examination of evidence from triple-negative breast cancer models regarding TENM4's functional impact.

Main Results:

  • TENM4 expression is elevated in multiple cancer types, with emerging evidence linking it to tumor cell plasticity and motility, potentially via focal adhesion kinase signaling.
  • Genetic silencing of TENM4 reduced spheroid formation and motility in vitro TNBC models.
  • Proposed TENM4 networks may influence cytoskeletal dynamics, cell adhesion, and transcriptional programs within the tumor microenvironment.

Conclusions:

  • TENM4 is an understudied molecule with potential implications in cancer cell plasticity and progression.
  • Further mechanistic studies and in vivo validation are crucial to confirm TENM4's role and therapeutic potential.
  • High-resolution interactomic approaches are needed to fully elucidate TENM4's molecular interactions and functions.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...